December 13, 2018
32 min listen

Giant Cell Arteritis with John Stone, MD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

In this episode, John Stone, MD, MPH, director of clinical rheumatology at Massachusetts General Hospital, sits down to discuss his approach to giant cell arteritis and the results of the GiACTA trial. Learn why Stone believes the most important diagnostic test in GCA is the patient’s history.

  • Intro :10
  • Background on Dr. Stone :59
  • The interview 2:10
    • Differentiating subtle GCA from the “classic case” 2:20
    • Data from Stone’s recent paper in Rheumatology 5:17
    • Using bilateral biopsies 9:00
    • Recommendations for temporal artery biopsy – who, when, where 11:13
    • Thoughts on imaging for GCA diagnosis 13:14
    • IL-6 and treatment of GCA 15:16
    • GiACTA trial – what surprised you most about the efficacy of prednisone alone? 19:05
      • Findings with tocilizumab 21:29
    • Inflammatory markers in GCA 24:47
    • Should we use tocilizumab right off the bat? 26:50
    • What excites you the most about the future of this field? 29:59
  • Thank you, Dr. Stone 31:33
  • Recap 31:38

We’d love to hear from you! Send your comments/questions to And be sure to follow us on Twitter @AdamJBrownMD and @HealioRheum.